Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
266 studies found for:    Open Studies | "Colitis, Ulcerative"
Show Display Options
Rank Status Study
1 Recruiting Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
Conditions: Ulcerative Colitis;   Digestive System Diseases;   Colitis, Ulcerative;   Colitis;   Gastrointestinal Diseases;   Inflammatory Bowel Diseases;   Intestinal Diseases;   Colonic Diseases;   Autoimmune Disease;   Abdominal Pain
Interventions: Drug: KHK4083;   Drug: Placebo
2 Recruiting Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Inflammatory Bowel Disease;   IBD
Intervention:
3 Recruiting Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
Condition: Colitis, Ulcerative
Intervention: Other: No Intervention
4 Recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Inflammatory Bowel Diseases
Interventions: Drug: Placebo IV;   Drug: Placebo SC;   Drug: Ustekinumab IV;   Drug: Ustekinumab SC
5 Unknown  Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients
Condition: Colitis, Ulcerative
Interventions: Drug: SB012;   Drug: Placebo
6 Recruiting The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Device: C2 videos;   Procedure: colonoscopy
7 Not yet recruiting GSK2982772 Study in Ulcerative Colitis Patients
Condition: Colitis, Ulcerative
Interventions: Drug: GSK2982772;   Drug: Placebo
8 Recruiting Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Inflammatory Bowel Diseases;   Colitis;   Intestinal Disease
Intervention: Other: Educational video
9 Recruiting Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients
Conditions: Colitis,Ulcerative;   Adenomatous Polyposis Coli;   Reservoir, Ileoanal
Intervention:
10 Recruiting Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
Condition: Colitis, Ulcerative
Intervention: Drug: Golimumab
11 Recruiting TD-1473 for Active Ulcerative Colitis (UC)
Conditions: Ulcerative Colitis, Active Moderate;   Ulcerative Colitis, Active Severe
Interventions: Drug: TD-1473;   Drug: Placebo
12 Recruiting Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis
Conditions: Ulcerative Colitis, Active Moderate;   Ulcerative Colitis, Active Severe
Interventions: Biological: Bertilimumab;   Biological: Placebo
13 Not yet recruiting Mercaptopurine Therapy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Mercaptopurine (Purinethol);   Drug: Placebo;   Drug: Mesalamine;   Drug: Prednisone
14 Not yet recruiting Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease
Conditions: Colitis, Ulcerative;   Crohn Disease
Intervention: Drug: Vedolizumab
15 Recruiting Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Aminosalicylic Acid
Interventions: Drug: Mesalazine;   Drug: Placebo
16 Recruiting Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention:
17 Recruiting An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: LYC-30937-EC;   Drug: Placebo
18 Not yet recruiting Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: LYC-30937-EC
19 Recruiting Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
Condition: Colitis, Ulcerative
Intervention: Drug: PF-06480605
20 Recruiting An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: Vedolizumab 300 mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years